We are live on ! Find out more
HI

Human Investing Portfolio holdings

AUM $771M
1-Year Est. Return 18.84%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+18.84%
3 Year Est. Return
+51.96%
5 Year Est. Return
+53.41%
10 Year Est. Return
–
AUM
$274M
AUM Growth
+$6.31M
Cap. Flow
+$537K
Cap. Flow %
0.2%
Top 10 Hldgs %
43.24%
Holding
380
New
39
Increased
75
Reduced
108
Closed
23

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$1.82M
2
DBI icon
Designer Brands
DBI
+$1.7M
3
IAA
IAA, Inc. Common Stock
IAA
+$1.48M
4
AMGN icon
Amgen
AMGN
+$1.11M
5
MCO icon
Moody's
MCO
+$1.04M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$3.34M
2
OPLN
Openlane
OPLN
+$1.51M
3
XLNX
Xilinx Inc
XLNX
+$1.43M
4
MSFT icon
Microsoft
MSFT
+$1.34M
5
PGR icon
Progressive
PGR
+$1.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.8%
2 Healthcare 10.63%
3 Technology 9.17%
4 Financials 5.98%
5 Consumer Staples 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRE icon
301
Sempra
SRE
$57.9B
$5K ﹤0.01%
76
– –
UAA icon
302
Under Armour
UAA
$2.84B
$5K ﹤0.01%
211
– –
ULTA icon
303
Ulta Beauty
ULTA
$22B
$5K ﹤0.01%
15
-10
-40% -$3.46K
APTV icon
304
Aptiv
APTV
$12B
$4K ﹤0.01%
50
– –
D icon
305
Dominion Energy
D
$60.8B
$4K ﹤0.01%
50
– –
EOLS icon
306
Evolus
EOLS
$385M
$4K ﹤0.01%
300
– –
IP icon
307
International Paper
IP
$21.6B
$4K ﹤0.01%
94
– –
PRLB icon
308
Protolabs
PRLB
$1.79B
$4K ﹤0.01%
35
– –
VRTX icon
309
Vertex Pharmaceuticals
VRTX
$121B
$4K ﹤0.01%
20
– –
RLH
310
DELISTED
Red Lions Hotel Corporation
RLH
$4K ﹤0.01%
500
– –
ALE
311
DELISTED
Allete
ALE
$3K ﹤0.01%
33
– –
CGC
312
Canopy Growth
CGC
$387M
$3K ﹤0.01%
7
+3
+75% +$1.32K
DLTR icon
313
Dollar Tree
DLTR
$24.4B
$3K ﹤0.01%
28
– –
EVV
314
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$3K ﹤0.01%
228
– –
IPG
315
DELISTED
Interpublic Group of Companies
IPG
$3K ﹤0.01%
+140
New +$3.11K
JBLU icon
316
JetBlue
JBLU
$2.28B
$3K ﹤0.01%
145
– –
KHC icon
317
Kraft Heinz
KHC
$30.7B
$3K ﹤0.01%
112
– –
MRVL icon
318
Marvell Technology
MRVL
$168B
$3K ﹤0.01%
108
– –
NLY icon
319
Annaly Capital Management
NLY
$17.1B
$3K ﹤0.01%
90
– –
PCAR icon
320
PACCAR
PCAR
$69.8B
$3K ﹤0.01%
60
– –
ALXN
321
DELISTED
Alexion Pharmaceuticals
ALXN
$3K ﹤0.01%
20
– –
BP icon
322
BP
BP
$116B
$2K ﹤0.01%
45
– –
BYND icon
323
Beyond Meat
BYND
$292M
$2K ﹤0.01%
+14
New +$1.56K
CC icon
324
Chemours
CC
$2.5B
$2K ﹤0.01%
81
-82
-50% -$2.42K
SPY icon
325
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$2K ﹤0.01%
7
– –
11 12
13
14 15

Similar funds

WI
Wahed Invest New York $770M AUM 37.1% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
PGA
Pilgrim Global Advisors Reno, Nevada $772M AUM 51.79% 1-Year Est. Return
SC
Sylebra Capital Palo Alto, California $774M AUM 56.69% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $775M AUM 18.57% 1-Year Est. Return
BPIM
Brant Point Investment Management New York $776M AUM 41.18% 1-Year Est. Return
TCM
Twin Capital Management Mcmurray, Pennsylvania $776M AUM 28.34% 1-Year Est. Return
PC
Permanens Capital New York $776M AUM 30.08% 1-Year Est. Return

Human Investing's Q2 2019 Portfolio in Review

As of Q2 2019, Human Investing held 380 positions worth $274M, up 2.4% from $268M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Human Investing's Q2 2019 filing shows 39 new, 75 increased, 108 reduced and 23 closed positions. Its largest new stake was Designer Brands: 83,217 shares worth $1.59M. The largest sale was Monster Beverage, an estimated $3.34M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, up from 9.6% a quarter earlier, followed by Healthcare and Technology.

  • Human Investing's largest Q2 2019 buy was Designer Brands: 83,217 shares worth $1.59M.
  • Human Investing added most to iShares Core MSCI EAFE ETF in Q2 2019, an estimated $1.82M increase.
  • Human Investing's biggest Q2 2019 reduction was Openlane, cutting an estimated $1.51M.
  • Human Investing fully exited Monster Beverage in Q2 2019, selling an estimated $3.34M.
  • Human Investing's ten largest holdings make up 43% of its $274M portfolio in Q2 2019.
  • Human Investing opened 39 new positions and closed 23 in Q2 2019.
  • Human Investing's portfolio value rose 2.4% quarter-over-quarter to $274M.

Based on Human Investing's 13F filing for Q2 2019, filed 16 Aug 2019.